OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
85 hedge funds and large institutions have $156M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
85
Holders Change
-1
Holders Change %
-1.16%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
28
Reduced
25
Closed
11
Calls
$7.57M
Puts
$3.19M
Net Calls
+$4.38M
Net Calls Change
+$3.78M
Top Buyers
1 |
1
BlackRock
New York
|
$15.6M |
2 |
2
Ameriprise
Minneapolis,
Minnesota
|
$6.27M |
3 |
3
Goldman Sachs
New York
|
$3.01M |
4 |
4
Primecap Management
Pasadena,
California
|
$17.6M |
5 |
CC
5
Cannell & Co
New York
|
$3.05M |